Showing 261 - 280 results of 44,951 for search 'Omarion~', query time: 6.72s Refine Results
  1. 261

    Potential Targeted Therapies in Ovarian Cancer by Yagmur Sisman, Lau Kræsing Vestergaard, Douglas Nogueira Perez de Oliveira, Tim Svenstrup Poulsen, Tine Henrichsen Schnack, Claus Høgdall, Estrid Høgdall

    Published 2022-10-01
    “…The mutational findings were held against clinically well-described data to identify potential targeted therapies in Danish patients diagnosed with high-grade serous ovarian cancer (HGSC). Methods: We characterized the mutational profile of 128 HGSC patients. …”
    Get full text
    Article
  2. 262
  3. 263

    Ovarian cancer, the coagulation pathway, and inflammation by Kavanagh John J, Wang Ena, Wang Xipeng, Freedman Ralph S

    Published 2005-06-01
    “…<p>Abstract</p> <p>Epithelial ovarian cancer (EOC) represents the most frequent cause of death in the United States from a cancer involving the female genital tract. …”
    Get full text
    Article
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269

    Cardiometabolic aspects of polycystic ovarian syndrome by Li Wei Cho, Harpal S Randeva, Stephen L Atkin

    Published 2007-03-01
    “…Finally the therapeutic options for treatment will be discussed.Keywords: cardiometabolic syndrome, polycystic ovarian syndrome, cardiovascular disease…”
    Get full text
    Article
  10. 270

    Risk factors for sporadic ovarian cancer by M. M. Vysotsky, M. A. Digayeva

    Published 2014-08-01
    “…The review of the literature on the problems of sporadic ovarian cancer details the present views of its disputable risk factors, such as dietary habits, body weight, contraception, and labor, and age of commencing a sexual activity. …”
    Get full text
    Article
  11. 271

    The Association Between Autophagy and Ovarian Cancer by Şayeste Demirezen, Merve Özcan, Sinan Beksaç

    Published 2012-08-01
    Subjects: “…Autophagy, Ovarian cancer, Chemotherapy…”
    Get full text
    Article
  12. 272
  13. 273
  14. 274

    New verification possibilities for ovarian malignancies by A. E. Protasova, R. V. Orlova, G. A. Raskin

    Published 2014-08-01
    “…The fact that the diagnosis can be significantly verified using the liquid-based cytology technique and immunocytochemical assain analyzed 72 cases with the ascites forms of ovarian cancer. The effective panel to diagnose ovarian adenocarcinomas with ascites may be considered as follows: Ber-EP4, calretinin for the differential diagnosis of the tumor with reactive changes, as well as estrog en receptors, WT-1, CK7 for the clarification of the type of adenocarcinoma (in case of a positive reaction to Ber-EP4). …”
    Get full text
    Article
  15. 275
  16. 276

    Management of ovarian carcinosarcomas (review of literature) by A. N. Gritsai, S. A. Shvachko, N. I. Lazareva, S. B. Peterson, A. P. Nikolaev

    Published 2014-07-01
    “…This review contains data on an aetiology, features of a clinical presentations and modern approaches in diagnostics and treatment of ovarian carcinosarcomas.…”
    Get full text
    Article
  17. 277

    Therapy resistance on the RADar in ovarian cancer by Jonas Schwickert, Franziska M Zickgraf, Martin R Sprick

    Published 2021-05-01
    “…Ovarian cancer has the worst prognosis of all gynecological cancers with high‐grade serous ovarian cancer (HGSOC) accounting for the majority of ovarian cancer deaths. …”
    Get full text
    Article
  18. 278
  19. 279

    Distress andneoangiogenesis in ovarian cancer patients by G. P. Guens, I. N. Oleynikova, N. A. Sirota, N. I. Moiseeva, V. E. Shikina, V. V. Kirkin

    Published 2019-04-01
    “…To evaluate the correlation between serum VEgF alevel and distress in ovarian cancer patients.Material and methods. The prospective cross-sectional study included 100 patients with stage i–iV ovarian cancer. the median age of the patients was 56 ± 9,56 years. …”
    Get full text
    Article
  20. 280